AAAAAA
Results:
1-24
|
Results: 24
Authors:
Thaker, GK
Carpenter, WT
Citation: Gk. Thaker et Wt. Carpenter, Advances in schizophrenia, NAT MED, 7(6), 2001, pp. 667-671
Authors:
Avila, MT
Conley, RR
Carpenter, WT
Citation: Mt. Avila et al., A comparison of symptom provocation procedures in psychiatry and other areas of medicine: Implications for their ethical use in research, BIOL PSYCHI, 50(7), 2001, pp. 479-486
Authors:
Kirkpatrick, B
Buchanan, RW
Ross, DE
Carpenter, WT
Citation: B. Kirkpatrick et al., A separate disease within the syndrome of schizophrenia, ARCH G PSYC, 58(2), 2001, pp. 165-171
Authors:
Carpenter, WT
Citation: Wt. Carpenter, Evidence-based treatment for first-episode schizophrenia?, AM J PSYCHI, 158(11), 2001, pp. 1771-1773
Authors:
Lahti, AC
Holcomb, HH
Medoff, DR
Weiler, MA
Tamminga, CA
Carpenter, WT
Citation: Ac. Lahti et al., Abnormal patterns of regional cerebral blood flow in schizophrenia with primary negative symptoms during an effortful auditory recognition task, AM J PSYCHI, 158(11), 2001, pp. 1797-1808
Authors:
Breier, A
Buchanan, RW
Irish, D
Carpenter, WT
Citation: A. Breier et al., Clozapine treatment of outpatients with schizophrenia: Outcome and long-term response patterns, PSYCH SERV, 51(10), 2000, pp. 1249-1253
Authors:
Carpenter, WT
Breier, A
Buchanan, RW
Kirkpatrick, B
Shepard, P
Weiner, E
Citation: Wt. Carpenter et al., Mazindol treatment of negative symptoms, NEUROPSYCH, 23(4), 2000, pp. 365-374
Authors:
Carpenter, WT
Conley, R
Kirkpatrick, B
Citation: Wt. Carpenter et al., On schizophrenia and new generation drugs, NEUROPSYCH, 22(6), 2000, pp. 660-661
Authors:
Kirkpatrick, B
Kopelowicz, A
Buchanan, RW
Carpenter, WT
Citation: B. Kirkpatrick et al., Assessing the efficacy of treatments for the deficit syndrome of schizophrenia, NEUROPSYCH, 22(3), 2000, pp. 303-310
Authors:
Kirkpatrick, B
Castle, D
Murray, RM
Carpenter, WT
Citation: B. Kirkpatrick et al., Risk factors for the deficit syndrome of schizophrenia, SCHIZO BULL, 26(1), 2000, pp. 233-242
Authors:
Carpenter, WT
Gold, JM
Lahti, AC
Queern, CA
Conley, RR
Bartko, JJ
Kovnick, J
Appelbaum, PS
Citation: Wt. Carpenter et al., Decisional capacity for informed consent in schizophrenia research, ARCH G PSYC, 57(6), 2000, pp. 533-538
Authors:
Carpenter, WT
Conley, RR
Citation: Wt. Carpenter et Rr. Conley, Sense and nonsense: an essay on schizophrenia research ethics, SCHIZOPHR R, 35(3), 1999, pp. 219-225
Authors:
Arango, C
Carpenter, WT
Queern, CA
Citation: C. Arango et al., Research ethics: A psychological approach., CLIN PSYCH, 19(3), 1999, pp. 384-385
Authors:
Carpenter, WT
Kirkpatrick, B
Buchanan, RW
Citation: Wt. Carpenter et al., Schizophrenia: syndromes and diseases, J PSYCH RES, 33(6), 1999, pp. 473-475
Authors:
Carpenter, WT
Citation: Wt. Carpenter, The schizophrenia ketamine challenge study debate, BIOL PSYCHI, 46(8), 1999, pp. 1081-1091
Authors:
Carpenter, WT
Arango, C
Buchanan, RW
Kirkpatrick, B
Citation: Wt. Carpenter et al., Deficit psychopathology and a paradigm shift in schizophrenia research, BIOL PSYCHI, 46(3), 1999, pp. 352-360
Authors:
Carpenter, WT
Zito, JM
Volavka, J
Citation: Wt. Carpenter et al., Dopamine, receptor occupancy and the action of clozapine: Does it make a difference to add a neuroleptic? Reply, BIOL PSYCHI, 46(1), 1999, pp. 147-149
Authors:
Carpenter, WT
Citation: Wt. Carpenter, The challenge to psychiatry as society's agent for mental illness treatment and research, AM J PSYCHI, 156(9), 1999, pp. 1307-1310
Authors:
Rafal, S
Tsuang, MT
Carpenter, WT
Citation: S. Rafal et al., A dilemma born of progress: Switching from clozapine to a newer antipsychotic, AM J PSYCHI, 156(7), 1999, pp. 1086-1090
Authors:
Arango, C
Adami, H
Sherr, JD
Thaker, GK
Carpenter, WT
Citation: C. Arango et al., Relationship of awareness of dyskinesia in schizophrenia to insight into mental illness, AM J PSYCHI, 156(7), 1999, pp. 1097-1099
Authors:
Amador, XF
Kirkpatrick, B
Buchanan, RW
Carpenter, WT
Marcinko, L
Yale, SA
Citation: Xf. Amador et al., Stability of the diagnosis of deficit syndrome in schizophrenia, AM J PSYCHI, 156(4), 1999, pp. 637-639
Authors:
Carpenter, WT
Buchanan, RW
Kirkpatrick, B
Lann, HD
Breier, AF
Summerfelt, AT
Citation: Wt. Carpenter et al., Comparative effectiveness of fluphenazine decanoate injections every 2 weeks versus every 6 weeks, AM J PSYCHI, 156(3), 1999, pp. 412-418
Authors:
Carpenter, WT
Buchanan, RW
Kirkpatrick, B
Breier, AF
Citation: Wt. Carpenter et al., Diazepam treatment of early signs of exacerbation in schizophrenia, AM J PSYCHI, 156(2), 1999, pp. 299-303
Authors:
Carpenter, WT
Conley, RR
Buchanan, RW
Citation: Wt. Carpenter et al., Schizophrenia, PHARMACOLOGICAL MANAGEMENT OF NEUROLOGICAL AND PSYCHIATRIC DISORDERS, 1998, pp. 27-51
Risultati:
1-24
|